Sanginita Chemicals Limited has informed the Exchange regarding Outcome of Board Meeting held on April 22, 2025.
SANGINITA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
The Board of Directors approved the audited financial results for the quarter and full year ended March 31, 2025. Total income for FY25 rose to Rs. 15,195.16 lakhs, up about 43.6% from Rs. 10,581.84 lakhs in FY24. The company swung from a net loss of Rs. 58.42 lakhs in FY24 to a net profit of Rs. 61.85 lakhs in FY25, with Q4 FY25 posting a standalone profit of Rs. 24.35 lakhs versus a loss of Rs. 58.42 lakhs in Q4 FY24. Cash flow from operations turned positive at Rs. 327.68 lakhs compared to a negative Rs. 229.65 lakhs in the previous year. The statutory auditor issued an unmodified (clean) opinion on the financial statements.
A clear operational turnaround – strong revenue growth, return to profitability and positive operating cash flow, supported by a clean audit report, is a positive development for shareholders and may support the stock sentiment.